-- Watson Wins EU Approval to Buy Generic-Drug Maker Actavis
-- B y   A o i f e   W h i t e
-- 2012-10-05T15:20:00Z
-- http://www.bloomberg.com/news/2012-10-05/watson-wins-eu-approval-to-buy-generic-drug-maker-actavis.html
Watson Pharmaceuticals Inc. (WPI) , maker
of the generic version of Lipitor cholesterol pills, won
European Union approval to buy closely held drugmaker  Actavis
Group hf  to create the third-largest global generic-drug maker.  The European Commission said the combined company would
continue to face competition from a sufficient number of
credible and strong rivals, according to an e-mailed statement
today.  Parsippany, New Jersey-based Watson agreed in April to buy
Actavis for 4.25 billion euros ($5.6 billion), expanding its
reach in  Europe  and  Asia .  To contact the reporter on this story:
Aoife White in Brussels at 
 awhite62@bloomberg.net .  To contact the editor responsible for this story:
Anthony Aarons at   aaarons@bloomberg.net . 